The Effect of Topical Fluocinonide Ointment on Phototherapy of Psoriasis  by LeVine, Mark J. & Parrish, John A.
0022-202X/ 82/ 0078-0 157$02.00/ 0 
THE JoU RNAL OF ] NVESTICA'I'IV E DERMATOLOGY, 78: 157-159, 1982 
Copyrigh l © 1982 by The Williams & Wilkins Co. 
Vol. 78, No.2 
Printed in. U.S.A. 
The Effect of Topical Fluocinonide Ointment on Phototherapy of 
Psoriasis 
MARK J. LEVINE, M .D., AND JOHN A. PARRISH, M.D. 
Department of Dermatology, Case Western Reserve University, (ML) Cleveland, Ohio, and Department of Dermatology, Harvard Medical 
School, Massachu.sett:s General Hospital (JP), Boston, Massa.clwsetts, U.S.A. 
The effect of fluocinonide ointment and 5% crude coal 
tar on clearance of plaque-type psoriasis vulgaris by 
phototherapy was studied in 25 hospitalized patients 
using the bilateral comparison technique. All treated 
areas received ultraviolet radiation from Westinghouse 
fluorescent FS-40 bulbs (290-400 nm) in doses calculated 
to produce a minimal delayed erythema. The topically 
applied compounds (fluocinonide ointment, 5% Crude 
coal tar, white petrolatum) were applied individually or 
in combination. In nearly all comparisons clearance of 
psoriatic plaques was obtained after the same number 
of ultraviolet exposures, although many (8 of 14) of the 
areas treated with fluocinonide ointment had an accel-
erated early response. It thus appears that although the 
use of topical corticosteroids may enhance the early 
therapeutic response of psoriatic plaques it does not 
hasten the clearance of these plaques. 
In 1931, Goeckerman 's repor t [1] that psoriasis was cleared 
with a regimen of repeated topical applications of crude coal 
tar (CCT) and subsequent exposure to ultraviolet radiation 
established the efficacy of this previously reported regimen 
(2]. In an attempt to define the minimum number of manipu-
lations necessary to clear psoriatic plaques, many investigators 
have examined the various components of the Goeckerman 
regimen [3-6]. It has become apparent that, when using doses 
of ultraviolet radiation calculated to produce a minimal and 
mild delayed erythema on normal appearing skin, the only 
topical application necessary is a bland emollient [6, 7]. 
A widely used modification of the Goeckerman regimen has 
been the addition of topical corticosteroids. Although the pre-
cise mechanism of therapeutic action is unknown, vasoconstric-
tion (8], reduction in inflammation (9], and decreased mitosis 
of epidermal cells [10] , have been found to occur after the 
topical application of corticosteroids. Despite a brief report [11] 
that attests to the efficacy of the combination of topical corti-
costeroids and UVB, (290-320 nm) there have been no con-
trolled studies of this regimen. Therefore using the bilateral 
comparison technique and clearance of lesions as the therapeu-
t ic endpoint, we evaluated the efficacy of UVB exposw-e with 
various combinations of 5% CCT, white petrolatum, and fluo -
cinonide ointment. 
MATERIALS AND METHODS 
Twenty-five patients (age range 22- 79 yr) with chronic plaque-type 
psoriasis vulgaris involving at least 15% (range 15-85%) of their body 
surface were hospi talized on a. dermatology wru·d or were admitted to 
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the clinical reseru·ch center (CRC) for the duration of this study. For 2 
weeks prior to the study and during the study no patient ingested or 
applied any medication known to affect psoriasis or photobiological 
responses to ultraviolet radiation. The only topical medications applied 
during the study were those specified below. All patients were aware 
that each side of their body would receive a different topical therapy 
and that consequently one side might cleru· faster than the other. All 
patients who agreed to pruticipate in the study were sequentia Lly 
div ided into groups 1 through 5. The endpoint for all patients was 
cleru·an ce of 95% of the psoriatic plaques. If clearance of one side 
preceded the other, 3 day were allowed before altering the therapy to 
obtain cleru·ance prior to dischru·ge. 
Prior to admission each patients' minimal erythema dose (MED) to 
UVB (FS 40 fluorescent sunlamps) was determined. Upon admission to 
the hospital or CHC each patient received a routine history and physical 
examination and was given a copy of the applicable protocol which wa 
reviewed with a physician and the floor nurse. T he protocol specified 
no occlusive wraps, no topical medications except those prescribed, and 
no moisturizers or lubricants. The first UV exposure was calculated to 
be 80% of the predetermined MED. Subsequent doses were determined 
by fo Llowing the previously described schedule [6]. 
Twenty-four of the patients received daily (7 t imes weekly) tota l 
body UV exposure: The other patient (17) received to tal body UV 
exposure 5 t imes weekly. The only exceptions were the contro l pa tches 
which received no UV exposure and any ru·ea t hat remained erythem-
atous 24 hr subsequent to UV exposure. Except for the scalp, where a 
salicylic acid lotion, tar shampoo, and corticosteroid lotion were used 
libera lly and free ly, the only topical unguents applied to the patients 
were 5% CCT in white petrolatum, flu odnonide oint rnent, or whi te 
petrolatum (WP) as prescribed in the fo llowing bilateral comparisons. 
Group 1 5% CCT in whi te petro latum + fluocinonide ointment vs 5% 
CCT in white petrolatum 
Group 2 5% CCT in whi te petrolatum + fluocinonide oin tment vs 
fluocinonide ointment . 
Group 3 Fluocinonide ointment + whi te petrolatum vs flu ocinonide 
ointment 
Group 4 Fluocinonide ointment + white petrolatum vs white petrola-
tum alone 
Group 5 5% CCT in white petrolatum + flu ocinonide ointment vs 
fluocinonide ointment + whi te petrolatum 
For all patients the daily routine involved: removing the tar prepa-
ration with minera l oil upon awakening; showering with wru·m water 
and soap (1 8 used an emollient soap and 7 used general hosp1 t.a l 
supplies); receiving total body UV exposure; afte r UV exposure and at 
bed t ime applying the topical unguents evenly to the entire appropriate 
side, avoiding the face and a ll in ter triginous ru·eas. 
Using the previously described [6] schedules a physician daily eval-
uated, graded, and recorded the clinical response and calculated the 
da ily UV exposure dose in the following manner. The firs t UV exposm e 
for each patient was calculated to be 80% of his minimal erythema dose. 
S ubsequent exposures were calculated using the fo llowing schedul e: (1) 
no erythema present-20% of previous dose + previous dose. (2) trace 
erythema present= repeat previous dose. (3) Definite (1+) erythema 
or tenderness-no UV exposure. 
Therepeutic effect was based on an evaluation of clinical response of 
scale induration and erythema as foliows: 
UV Source 
0 = 0- 25% clearance of lesions 
1 + = 26- 50% cleru·ance of lesions 
2+ = 51-75% cleru·ance of lesions 
3+ = 76- 95% cleru·ance of lesions 
4+ = greater than 95% clearance of lesions. 
AU treatments were de livered in walk-in cylindrical irradiation cham-
bers using Westinghouse FS 40 fluorescent sunlamps. Spectral irradi-
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ance measurements were made using an International Light Inc., Model 
700 spectroradiometer. The irradiance of wavelengths in the 280-315 
nm band at a distance of 10 em was 880 Jl.W/cm" for one chamber 
(Boston) and 110 Jl.W/cm2 for the other (Cleveland). 
AlLbaugh the spectral power distribution of these lamps extends 
from 280 nm into the visible region with a broad peak at 313 nm, 
erythemogenesis is due almost entirely to the UVB component (280-
315 nm). Identical bulbs were used for all MED determinations. 
RESULTS 
Psoriatic plaques were cleared (leaving only macular hyper-
pigmentation or normal appearing skin) in essentially the same 
number of treatments when exposed to doses of UVB that are 
calculated to produce a minimal erythema in combination with 
either 5% CCT, white petrolatum, fluocinonide ointment, 5% 
CCT plus fluocinonide, or white petrolatum plus fluocinonide 
(Table I). In 12 of 13 bilateral comparisons where fluocinonide 
was the variable being evaluated (gToups I ,IV) there was no 
difference in the number of treatments required for clearance 
of the psoriatic plaques. In 1 of the 13 comparisons the side 
treated with fluocinonide was not clear when the contralateral 
side was clear. In 3 comparisons (pts #1, 12 & 16; see Table I) 
the stage of clearance differed at the time of final evaluation. In 
the 2 comparisons where fluocinonide alone was less effective 
in clearing the plaques, the psoriasis seemed unusually respon-
sive requiring only 12 (pt #16) and 14 (pt #12) treatments. In 
the remaining comparison plaques treated with 5% CCT cleared 
more rapidly than those treated with 5% CCT and fluocinonide. 
Although the endpoint (clearance) was reached at the same 
time in nearly ail the comparisons, early in the treatment the 
rate of clearance varied. The addition of fluocinonide to either 
5% CCT (gToup I) or WP (gToup IV) led to more rapid improve-
TABLE l. Final grading of psoriasis at clearance of at least one side 
,Group Pt. No. of A B treatments 
I A 5% crude coal tar (5% 1 19 4+ 3+ 
CCT) 2 11 4+ 4+ 
B 5% crude coal tar + 3 16 4+ 4+ 
fluocinonide ointment 4 19 4+ 4+ 
5 16 4+ 4+ 
6 21 4+ "4+ 
7 22 4+ 4+ 
II A 5% CCT + flucinonide 8 18 4+ 4+ 
ointment 
B fluocinonide ointment 9 24 4+ 4+ 
10 23 4+ 4+ 
11 11 4+ 4+ 
12 14 3+ 4+ 
IliA fluocinonide ointment + 
whi te Petrolatum 
B fluocinonide ointment 13 24 4+ 4+ 
14 22 4+ 4+ 
15 15 4+ 4+ 
16 12 3+ 4+ 
IV A white petrolatum 
B fluocinonide ointment+ 17" 27 4+ 4+ 
white petrolatum 18" 21 4+ 4+ 
19" 12 4+ 4+ 
20" 8" 3+ 3+ 
21" 22 4+ 4+ 
22" 26 4+ 4+ 
23" 15 4+ 4+ 
v A white petrolatum + 
fluocinonide ointment, 
B 5% CCT in white petro- 24" 17 4+ 4+ 
tatum + fluocinonide 25" 27 4+ 4+ 
ointment 
" Patients #17 through 25 were treated at University Hospitals, 
Cleveland, Ohio. 
"After 8 treatments the side treated with fluocinonide was suffi-
ciently more improved than t he other side that the patient requested 
fluocinonide be applied to both sides. 0.05% fluocinonide ointment was 
used as Lidex brand commercially available stock. 
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TABLE II. Graded response of psoriatic plaque after the fifth 
treatment 
Group 
I A 5% crude coal tar (5% 
CCT) 
B 5% crude coal tar + fluoci-
nonide ointment 
II A 5% CCT + fluocinonide 
ointment 
B fluocinonide ointment 
III A fluocinonide ointment + 
whiLe petrolatum 
B fluocinonide ointment 
IV A white petrolatum 
B fluocinonide ointment + 
white petrolatum 
V A white petrolatum + fluo-
cinonide ointment 
B 5% CCT in white petrola-
tum + fluocinonide oint-
ment 
TABLE III." 
5% CCT + white petrolatum 
(WP) fluocinonide (groups I, II, 
V) 
WP + fluocinonide (groups III, 
IV, V) 
Fluocinonide (groups II, III) 
5% CCT + WP (group I) 



































































"The total number of comparisons treated with the various topical 
compounds individually or in combination and the average number of 
treatments to clearance ru·e calculated. Case #8 is excluded from these 
calculations. 
ment during the first 5-10 treatments (Table II). Those areas 
treated with WP with UVB improved most slowly. However by 
the 8th to lOth treatment the differences between the 2 sides 
was minimal and was no longer detectable after the. lOth 
treatment. When both sides were treated with fluocinonide 
(gToups II, III, and V) the rate of clearance was similar for each 
side. 
When the bilateral comparison method is used, one can draw 
conclusions with smaller test populations; this technique also 
allows one to obtain larger sample sizes for any specific regimen. 
For example, gTOup I (Table I) consists of 7 patients each of 
whom were treated on one side of their body with 5% CCT in 
white petr.olatum and with fluocinonide ointment. However, 
groups II and V also had one side of their body treated in a 
similar fashion and consequently a total of 14 patients were 
treated with thjs regimen (Table III). When the average number 
of treatments needed for clearance are calculated for each 
regimen used in this study, there is little difference among the 
gToups. Further the average number of treatments (18.9) re-
quired for clearance for all regimens using fluocinonide was 
nearly identical to the number required with fluocinonide oint-
ment (19.0) . 
The control patches often were improved but the improve-
ment never paralleled that of the treated areas. In addition, the 
control patches never attained total clearance. Control patches 
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never received UV exposure, but were treated with whichever 
topical regimen was appropriate for the immediately adjacent 
skin. 
There were no detectable differences in the erythema re-
sponses in any of the bilateral comparisons. At some point in 
the treatment course each patient had an erythema sufficient 
to cause us to withhold at least one UV exposure. Erythema 
appeared both early and late in the treatment course and in 
both a symmetric and asymmetric pattern. There were no 
instances of blister formation or ankle edema as previously 
described (6]. In 2 patients (both in group 4) slightly tender 
nonpruritic symmetric erythematous papules developed after 
14 treatments. Histologic examination of punch biopsy of these 
lesions showed no epidermal changes, and a mild perivascular 
lyrnphohistiocytic dermal infiltrate. These lesions resolved with 
no residue when both the UV exposure and topical applications 
were stopped. 
DISCUSSION 
In the more than flfty-five yr of clinical experience with the 
Goeckerman regimen the precise underlying mechanism of its 
therapeutic effectiveness has not been elucidated. Recent in-
vestigations indicate that application of topical emollients in 
combination with UVB exposure is as effective as the combi-
nation of tar applications and UVB exposure when using doses 
of UVB calculated to be minimally erythemogenic [6,7]. This 
result might be explained by an enchanced transmission of the 
therapeutically effective ultraviolet wavelengths (accompanied 
by a measured immediate decrease in remittance of these 
wavelengths) by substances whose index of refraction closely 
matches the index of refraction of skin (12]. Despite the relative 
paucity of information concerning the basic therapeutic mech-
anism, the Goeckerman regimen has been repeatedly modified. 
A major modification has been the introduction of the con-
commitant use of topical corticosteroids and UV exposure. 
Since 1952 when hydrocortisone was found to be effective in 
the therapy of inflammatory dermatoses [13], the development 
of increasingly potent topical corticosteroids has helped revo-
lutionize dermatologic therapy. As the potency of these com-
pounds has increased many questions concerning local side 
effects, the rebound phenomenon, tachyphylaxis (14,15], and 
length .of remission (16,17] have arisen. 
During the course of treatment all patients in this study had 
clinical signs of phototoxicity (erythema and tenderness). Pho-
totoxicity and the tender erythematous papules (cases 21 and 
22) involved bilateral or asymmetric ru:eas with no predilection 
for any anatomic site or test combination. Coal tar solution has 
been shown to offer modest but detectable photoprotection and 
to thus decrease the erythema from a specific dose of UV 
[18,19]. Since in the current study phototoxicity was as likely 
to appear in areas treated with CCT as in ru·eas treated with 
fluocinonide ointment it appears that topical corticosteroids 
offer little or no additional benefit in preventing UVB-induced 
erythema. 
In only 3 of the 25 patients studied was there a difference in 
the grading of the level of improvement when one side had 
attained clearance. In all 3 cases the side that was slower to 
clear was treated with fluocinonide ointment. In 2 of the 3 cases 
the slower responding side was treated with only fluocinonide 
ointment and UVB (lacking either an additional emollient or 
5% crude coal tar). In all 25 patients the fastest (eru·liest) 
improvement was noted in the areas treated with fluocinonide. 
Early in the treatment course those areas treated with either 
WP or 5% CCT alone (plus UVB) improved more slowly than 
did the matched comparison sites that were treated with UVB, 
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WP or 5% CCT, and fluocinonide ointment. However by the 
tenth treatment the differences in improvement were no longer 
detectable in 12 of 13 comparisons. This observation might be 
explained by the phenomenon of tachyphylaxis. 
Alternatively one might postulate that the therapeutic effects 
of UVB phototherapy are cumulative and therefore repeated 
exposures are necessru·y before the clinical response is noticea-
ble. This might lead one to begin a modified "Goeckerman" 
regimen (or, perhaps more appropriately UVB phototherapy 
for psoriasis) with a combination of UVB, topical fluorinated 
corticosteroids, and an emollient. After seven to ten UVB 
exposures one could discontinue the corticosteroids and attain 
as rapid and complete a response. However the use of topical 
corticosteroids might make subsequent management more dif-
ficult as was shown in one study combining topical steroids and 
PUV A [17] or make the psoriasis more likely to relapse [16]. 
Additionally since the average number of treatments (18.9) 
required with fluocinonide ointment was identical to the num-
ber (19.0) required without fluocinonide one could attain as 
rapid a response with minimally erythemogenic doses of UVB 
and an emollient as with any combination of minimally ery-
themogenic doses of UVB, fluocinonide ointment, and crude 
coal tar. It is entirely possible that other types and routes of 
administration (e.g., intralesional) of corticosteroids might lead 
to a greater enhancement of therapeutic effect than did the 
topical corticosteroid ointment used in this study. 
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